Disruptors

Walgreens Boots Alliance's healthcare unit reported $1.6 billion in revenue as the retail pharmacy giant turns toward primary care and healthcare.

CVS Health will continue to dispense drugs that are FDA-approved and legal as the country faces an "unacceptable" slide in protecting women's health, the company's CEO, Karen Lynch, told an audience in Washington, D.C., March 29.

Walgreens CEO Rosalind Brewer called the company's second quarter "transformational" because of the continued growth of VillageMD and its $8.9 billion acquisition of provider group Summit Health.

Tune into this episode featuring Dr. Madeleine McDowell, Senior Principal and Medical Director of Intelligence and Trevor DaRin, Senior Consulting Director of Intelligence at Vizient. Learn about how systems embrace disruptions, how using analytics helps identify growth opportunities, top priorities…

Elon Musk's Neuralink is reportedly in talks with medical centers to test its brain implants on humans, Gizmodo reported.

What is the best hospital in the United States? After asking ChatGPT that question on Feb. 20, Becker's posed the same query to Google's Bard AI. And the two artificial intelligence chatbots had different responses.

Environmental, social and governance investment group Arjuna Capital is claiming a win after CVS Health committed to strengthening its reproductive health data privacy protections following a shareholder proposal from the activist investment group.

CVS and Optum have struggled to integrate behavioral health into their payer-provider models, Behavioral Health Business reported.

Dr. Thomas Moshiri, Chief Business Officer, Arizona Pain Relief talks about how he sees industry trends changing in the next few years, trends he's following, and a lot more.

In this episode, we are joined by Carol Stanfill the VP of US Ambulatory Surgery Centers at DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, to discuss the state of the ASC market, capabilities in this space, and emerging…